Clinical Trial Update: Comparison of Reduced Fluence Versus Standard Photodynamic Therapy (in Combination With Intravitreal Triamcinolone Acetate) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing reduced fluence photodynamic therapy versus standard photodynamic therapy, each in combination with intravitreal triamcinolone acetoni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• TRIAMCINOLONE ACETONIDE (TRIAMCINOLONE ACETONIDE)
• Verteporfin (Visudyne) (verteporfin)

Snippet

Sponsor: Medical University of Vienna | Conditions: Macular Degeneration | Phase 3 | Status: COMPLETED